Raj Mehta
raj-mehta.bsky.social
Raj Mehta
@raj-mehta.bsky.social
#FamilyMedicine, Clinical Informaticist, EBM & Bioethics enthusiast | Faculty AdventHealth Family Medicine Residency | UFMEDICINE alum
Reposted by Raj Mehta
It's finally here! SURPASS CVOT trial results! This is an interesting blend of benefits. The quick summary is tirzepatide is better for renal outcomes, A1c, weight and all cause mortality. For cardiovascular outcomes it's essentially equivalent/slightly better to a monoagonist GLP1. Let's dive in 🧵
September 18, 2025 at 3:28 PM
Reposted by Raj Mehta
The new ⌚️ will have hypertensive notifications

This doesn’t seem like a cuffless BP - but more like a notification ‘you may have hypertension, go check your BP’ ?

From www.apple.com/newsroom/202...

@jordybc.bsky.social @drwanpen.bsky.social @spjuraschek.bsky.social @daichishimbo.bsky.social?
September 9, 2025 at 8:35 PM
Reposted by Raj Mehta
Some key changes that stood out to me (got the opportunity to help w writing these!):

1) Stronger recs for single pill combos
2) Broader recs for screening for primary aldo (now consider in anyone with stage 2 HTN — i.e., BP >=140/90)
3) Just. Say. No… to cuffless BP devices… and to EtOH

2/
No.to
August 14, 2025 at 6:10 PM
Reposted by Raj Mehta
should we screen for CKD in the general population?

Finally, flozins, finerenone and GLP1s allow a good cost-effectiveness case

www.nephjc.com/news/2025/7/... for #NephJC shorts

Time to stop just being dialysis-ologists and flozinate, glipinate!

#NephSky
NephJC Shorts: Should we Screen for Kidney Disease? — NephJC
Should we screen for CKD?
www.nephjc.com
July 31, 2025 at 5:45 PM
Reposted by Raj Mehta
Heard from #AHRQ that the entire grants staff has been let go! They are unable to issue funds for grants already funded, let alone fund new grants. This is outrageous and will make Americans poorer and sicker. Why? A brief thread about just some recent AHRQ-funded research: #MedSky #HealthPolicy
July 23, 2025 at 10:59 PM
Reposted by Raj Mehta
This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%!

Practice changing investigator-initiated RCT.

#ISTH2025
June 22, 2025 at 1:49 PM
Reposted by Raj Mehta
Rubio terminated 5800 USAID contracts – more than 90% of its foreign aid programs – in defiance of the courts.

Here’s a list of just some of the lifesaving awards that were terminated. Nearly all were Congressionally mandated. They’ve saved millions of lives. 🧵
February 27, 2025 at 8:59 PM
Reposted by Raj Mehta
A randomized trial of tailored A.I.-guided ablation of atrial fibrillation vs standard-of-care, anatomical ablation demonstrated superiority of AI guidance
www.nature.com/articles/s41...
February 14, 2025 at 2:44 PM
Reposted by Raj Mehta
I wrote a book The Creative Destruction of Medicine (2013, title adopted after Schumpeter).

This title of the book for what we are now seeing in the U.S. is just The Destruction of Medicine.
February 14, 2025 at 11:15 PM
Reposted by Raj Mehta
Indirects support infrastructure for translational research and clinical trials. Look for clinical trials to be paused or halted because universities will no longer have funds to keep them open. This will be devastating for cancer patients at NCI-designated comprehensive cancer centers, for example.
Medical and health research will be especially badly hit, since medical schools rely more heavily on grant funding from NIH relative to other parts of the university.
February 8, 2025 at 2:35 PM
Reposted by Raj Mehta
I have a piece half-done on the entire world of indirect costs. It's too big an endeavor to finish now, in the middle of the night, when this problem *that was always a live grenade with a half-pulled pin* is suddenly a topic du jour. Shit of a thing.

Here are some highlights.
February 8, 2025 at 5:59 AM
Reposted by Raj Mehta
A randomized trial of GPT-4 vs 92 physicians with or without this #AI LLM for performance on patient care tasks.
AI improved physician performance, on par with AI alone (based on 5 clinical vignettes) nature.com/articles/s41...
GPT-4 assistance for improvement of physician performance on patient care tasks: a randomized controlled trial - Nature Medicine
In a prospective study involving 92 physicians from multiple institutions, access to large language model assistance on top of conventional resources increased a score expressing the quality of their ...
nature.com
February 5, 2025 at 3:51 PM
Reposted by Raj Mehta
From JAMA Cardiology:

South African regulations limiting sodium in processed foods were associated with reductions in sodium consumption and blood pressure among rural adults aged 40 years or older.

ja.ma/4hMWyUW

#CardioSky
February 5, 2025 at 7:29 PM
Reposted by Raj Mehta
In @ajkd.bsky.social

www.ajkd.org/article/S027...

Revisiting protein restriction: did they get it wrong?

Yes they did it wrong.

But they don’t admit that in this commentary, sadly 😕
January 30, 2025 at 10:03 PM
Reposted by Raj Mehta
Finally!

Antibiotics are not non-inferior to appendectomy despite a generous 20% non-inferiority margin

They are actually inferior: www.thelancet.com/journals/lan... in the @thelancet.bsky.social

#MedSky
January 17, 2025 at 3:06 AM
Reposted by Raj Mehta
The potential importance of reactivation of herpes simplex virus type 1 (HSV-1) as a contributing factor to developing Alzheimer's disease
www.science.org/doi/10.1126/...
January 7, 2025 at 7:39 PM
Reposted by Raj Mehta
A protein intake of 1.5 g/kg/day enhances net protein balance in older adults on a two-meal eating pattern.

by Church DD, Hirsch KR (...) Ferrando AA et 5 al. in J Nutr #MedSky

📖 read the article:
Effect of Three Different Daily Protein Intakes in a Two-Meal Eating Pattern on Protein Turnover in Middle Age and Older Adults: A Randomized Controlled Trial
Reduced meal frequency patterns have become popular for weight loss, maintenance, and improving cardiometabolic health. The extended fasting windows w…
www.sciencedirect.com
January 6, 2025 at 6:36 PM
Reposted by Raj Mehta
We need some of these phrases for nephrology!

Kidney failure = Filter futility

Peritoneal dialysis = Abdominal cleaning

Hyponatremia = Salt shortage
December 20, 2024 at 1:09 PM
Reposted by Raj Mehta
THREAD

This Is The Story Of The The Pernicious Rise of AI-Generated Papers and their Online Impact

An Incomplete History Told In The Voice of Documentarian Adam Curtis
1/31
December 19, 2024 at 9:10 PM
Reposted by Raj Mehta
🚨New in Nature Computational Science! 🚨

Do large language models (LLMs) exhibit social identity biases like humans?

(co-lead by @tiancheng.bsky.social, together with @steverathje.bsky.social, Nigel Collier, @profsanderlinden.bsky.social, and Jon Roozenbeek)
1/
www.nature.com/articles/s43...
Generative language models exhibit social identity biases - Nature Computational Science
Researchers show that large language models exhibit social identity biases similar to humans, having favoritism toward ingroups and hostility toward outgroups. These biases persist across models, trai...
www.nature.com
December 12, 2024 at 12:33 PM
Reposted by Raj Mehta
The data speaks for itself
December 6, 2024 at 5:55 PM
Reposted by Raj Mehta
#MedSky #NephSky

🛣️ BPROAD takes the known path of ACCORD trial, minus glycemic control

🎯Question to address: should we aim for a BP of 120 or 140 in patients with diabetes?

#NephJC summary by @shahsonride.bsky.social and @madihaaziz.bsky.social

www.nephjc.com/news/bproad
BPROAD: Sprinting down the BP Road in DIabetes — NephJC
This week, we will discuss hopefully the final story of intensive BP lowering. BPROAD is a larger version of ACCORD without the glycemic control arm. Dive in.
www.nephjc.com
December 3, 2024 at 2:49 AM
The Art of Uncertainty: How to Navigate Chance, Ignorance, Risk and Luck
bjgplife.com
December 1, 2024 at 12:13 PM